Meijers M, Woutersen R A, van Garderen-Hoetmer A, Bakker G H, de Jong F H, Foekens J A, Klijn J G
Department of Biological Toxicology, TNO Toxicology and Nutrition Institute, Zeist, The Netherlands.
Carcinogenesis. 1991 Sep;12(9):1707-13. doi: 10.1093/carcin/12.9.1707.
We studied the effects of hormonal manipulation by orchiectomy, alone or in combination with the aromatase inhibitor aminoglutethimide (AGT), and by luteinizing hormone-releasing hormone agonist (LH-RH-A) (goserelin) treatment on the development of early putative (pre)neoplastic lesions induced in the pancreas of rats and hamsters by azaserine and N-nitrosobis(2-oxopropyl)amine respectively. Treatment of the animals started 1 week after the last injection with carcinogen and continued for 4 months. Orchiectomy caused a significant inhibition of growth of acidophilic atypical acinar cell nodules in the rat model, whereas surgical castration did not show an effect in the hamster model. In rats, but not in hamsters, orchiectomy resulted in a significant decrease in body weight and in absolute, but not relative pancreatic weight. Treatment of the animals with AGT or goserelin did not cause a significant effect on the development of either putative preneoplastic acinar lesions in rat pancreas or early ductular lesions in hamster pancreas. Hamsters showed clearly higher plasma epidermal growth factor (EGF) and insulin-like growth factor 1 (IGF-1) concentrations than rats, while plasma testosterone levels were significantly lower. Plasma EGF and IGF-1 levels decreased with increasing age in both control and treatment groups. Compared to controls there were no clear unequivocal effects of treatment on EGF, IGF-1 and gastrin levels. Plasma testosterone levels decreased by orchiectomy and LH-RH-A treatment. In rats hormone-induced effects on food intake and altered nutritional status might be important with respect to the development of carcinogen-induced preneoplastic pancreatic lesions.
我们研究了去势单独或联合芳香化酶抑制剂氨鲁米特(AGT)进行激素调控,以及使用促黄体生成素释放激素激动剂(LH-RH-A)(戈舍瑞林)治疗对分别由氮杂丝氨酸和N-亚硝基双(2-氧代丙基)胺在大鼠和仓鼠胰腺中诱导的早期假定(前)肿瘤性病变发展的影响。在最后一次注射致癌物1周后开始对动物进行治疗,并持续4个月。去势在大鼠模型中显著抑制了嗜酸性非典型腺泡细胞结节的生长,而手术阉割在仓鼠模型中未显示出效果。在大鼠中,而非仓鼠中,去势导致体重显著下降,以及胰腺绝对重量下降,但相对重量未下降。用AGT或戈舍瑞林治疗动物对大鼠胰腺中假定的肿瘤前腺泡病变或仓鼠胰腺中的早期导管病变的发展均未产生显著影响。仓鼠的血浆表皮生长因子(EGF)和胰岛素样生长因子1(IGF-1)浓度明显高于大鼠,而血浆睾酮水平则显著较低。在对照组和治疗组中,血浆EGF和IGF-1水平均随年龄增长而下降。与对照组相比,治疗对EGF、IGF-1和胃泌素水平没有明确的显著影响。去势和LH-RH-A治疗使血浆睾酮水平降低。在大鼠中,激素诱导的对食物摄入和营养状况改变的影响可能对致癌物诱导的胰腺肿瘤前病变的发展具有重要意义。